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To the Editor: the effect of genetic factors on the response to vitamin D supplementation 1 
may be mediated by vitamin D binding protein concentrations 2 
We welcome the paper by Yao et al. (1), presenting the vitamin D binding (DBP) genotype 3 
distribution and concentrations and their influence on the response to vitamin D 4 
supplementation in a large cohort of Chinese adults. There are however several points the 5 
reader should consider in the interpretation of these data.  6 
Yao et al. report that supplementation with 2,000IU vitamin D per day failed to correct 7 
vitamin D deficiency in 25% of Chinese participants. They used the Endocrine Society (ES) 8 
thresholds for vitamin D deficiency for clinical populations (a plasma 25 hydroxy vitamin D 9 
(25(OH)D) concentration <50nmol/L) (2). The ES however recommends that for the 10 
correction of vitamin D deficiency an 8-week loading schedule of 50,000IU/week followed 11 
by a maintenance dose of 1,500-2,000IU/d for adults should be used. However for a study 12 
amongst healthy community dwelling adults, without conditions that may increase their 13 
vitamin D requirements, the use of population guidelines (e.g. that of the Institute of 14 
Medicine (3)) would have been more appropriate.  15 
The authors appear to suggest that there are major racial differences in the increment of 16 
25(OH)D in the response to vitamin D supplementation. However, the selected papers do 17 
not represent the balance of available evidence, which shows a lack of influence of race on 18 
the dose-response to vitamin D supplementation, albeit this was mostly based on black and 19 
white populations (summarised by EFSA (4)). The authors suggest that the low increment in 20 
25(OH)D in Chinese participants may be caused by the predominant vitamin D binding 21 
protein (DBP) genotypes in this population and the associated differences in the binding 22 
affinity for 25(OH)D. In support of this statement the authors quote the paper by Arnaud, 23 
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1993 (5). However, where Arnaud used vitamin D as a tracer and reported DBP genotype-1 
dependent differences in the affinity for 25(OH)D by extrapolation, other studies using 2 
[3H]25(OH)D  showed small, if any differences (6-8). The DBP genotype-dependent 3 
differences in baseline 25(OH)D and the increment in its concentration after 4 
supplementation reported by Yao, may be predominantly determined by the genotype-5 
dependent differences in DBP concentrations. Through this mechanism, DBP genotype may 6 
influence the fraction of 25(OH)D available for cellular uptake and hydroxylation (9).   7 
Finally, the authors suggest that the response to vitamin D supplementation was greater for 8 
total 25(OH)D than for 25(OH)DBio by comparing their respective changes, while ignoring 9 
differences in their absolute values. A calculation of their proportional change shows that 10 
these are similar (+105 and 107% for total and 25(OH)DBio, respectively), a finding that is to 11 
be expected since 25(OH)DBio is derived from the concentrations of total 25(OH)D and its 12 
binding proteins, DBP and albumin. The latter are known not to respond to vitamin D 13 
supplementation (10).  14 
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